# ABREVA

NDC: 0135-0300
Generic name: docosanol
Labeler / Manufacturer: Haleon US Holdings LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20220325

FDA application: ANDA208754

## Active ingredients

- DOCOSANOL: 100 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0135-0300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0135-0300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf02c8c5-af60-41f1-a202-38a97491a720